Iodeto De Potássio Gl Pharma

Potassium Iodide, the active ingredient in Iodeto De Potássio Gl Pharma, is an iodide presented as an oral formulation for oral use. It provides stable iodide ions that saturate the thyroid gland, thereby reducing the uptake of radioactive iodine isotopes and is also used to prevent iodine deficiency in at‑risk populations.

GNH USA supplies Iodeto De Potássio Gl Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, including major academic medical centres and regional health systems.

Potassium Iodide acts on the thyroid gland to block iodine uptake and is employed in radiation‑related and nutritional contexts. - Radiation emergency exposure: reduces thyroid uptake of radioactive iodine isotopes. - Iodine deficiency prevention: supplies essential iodine to populations at risk of deficiency. - Nuclear medicine procedures: blocks thyroid absorption of administered iodine to protect gland function.

Potassium Iodide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Metallic or salty taste in the mouth. - Mild gastrointestinal upset, such as nausea or stomach discomfort. - Headache or mild dizziness. - Transient skin rash or itching. - Mild increase in salivation.

Serious or Rare Side Effects: - Allergic reactions, including anaphylaxis. - Severe skin eruptions such as Stevens‑Johnson syndrome. - Significant thyroid dysfunction (hypo‑ or hyper‑thyroidism). - Hyperkalemia, especially in patients with renal impairment. - Respiratory distress or severe vomiting.

Potassium Iodide should be used with attention to specific health conditions and handling requirements. - Pregnancy: consult a healthcare professional; limited safety data are available. - Breastfeeding: use with caution as iodide may be secreted in breast milk. - Renal impairment: monitor serum potassium levels closely. - Pre‑existing thyroid disease: administer only under specialist supervision. - Drug interactions: review all concomitant medications for potential conflicts. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Potassium Iodide can interact with several medicines, requiring monitoring or avoidance.

Major Interactions (Avoid): - Thyroid hormone replacement therapy: may diminish therapeutic effect. - Lithium: increased risk of thyroid dysfunction. - ACE inhibitors or ARBs: heightened risk of hyperkalemia.

Moderate Interactions (Monitor Closely): - Potassium‑sparing diuretics: monitor serum potassium. - Amiodarone: additive iodine load may affect thyroid. - Antacids containing aluminum or magnesium: may reduce iodide absorption.